February 27 Jesse Watters: Democrats are having second thoughts about this Fox News host Jesse Watters discusses the former president's deposition on the Epstein files on 'Jesse Watters Primetime.'
February 27 There is a lot we don’t know about the Epstein investigation: Barry Levine ‘The Spider’ author Barry Levine says we are seeing the trial that would have happened had Jeffrey Epstein not died on ‘Jesse Watters Primetime.’
February 27 Laura returns to her old stomping grounds at Dartmouth Fox News host Laura Ingraham reflects on returning to her alma mater, Dartmouth, and discussing diverse viewpoints with students on ‘The Ingraham Angle.’
February 27 Former acting ICE chief Jonathan Fahey: This is entirely preventable Former Acting I.C.E. Director Jonathan Fahey discusses the impact of soft-on-crime policies on 'The Ingraham Angle.'
February 27 'Raymond's Rules for Air Travel': No more bunny slippers in the TSA line Fox News contributor Raymond Arroyo discusses TSA's unique way of ensuring security on 'The Ingraham Angle.'
February 27 Bill Clinton wanted to answer every question, Rep. Nick Langworthy says Rep. Nick Langworthy, R-N.Y., and Rep. Pat Fallon, R-Texas, discuss the former president's deposition in the Epstein investigation on 'The Ingraham Angle.'
February 27 US, Iran still at odds over fundamental issues Fox News senior foreign policy correspondent Gillian Turner reports on the latest in the mounting tensions between the U.S. and Iran amid negotiations on 'Special Report.'
February 27 The Iranians haven’t exactly been ‘bending over backwards,’ former counterterrorism coordinator says Former U.S. Ambassador-at-Large Nathan Sales explains why the Trump administration has set a clear red line on any sort of nuclear enrichment on ‘The Ingraham Angle.’
February 27 Mission to circle the moon delayed until April Fox News senior correspondent Jonathan Serrie has the latest on the space exploration schedule on 'Special Report.'
February 27 Longevity research, AI accelerating race for cancer cures Dr. Patrick Soon-Shiong, executive chairman of the Los Angeles Times and ImmunityBio, discusses efforts to target cancer’s evolving characteristics and how artificial intelligence is accelerating the development of new treatments on ‘Special Report.’
